| related words |
| riquent |
| costar |
| labcorp |
| nda |
| sublicense |
| antara |
| qutenza |
| clinically |
| linaclotide |
| lifescan |
| investigational |
| pulsys |
| pma |
| inhibitor |
| glumetza |
| recombinant |
| telavancin |
| erbitux |
| veridex |
| eventual |
|
| related documents |
| 857728--3/30/2007--I_FLOW_CORP_/DE/ |
| 815838--3/13/2009--NOVEN_PHARMACEUTICALS_INC |
| 1172480--3/4/2008--SANTARUS_INC |
| 815838--4/1/2008--NOVEN_PHARMACEUTICALS_INC |
| 1128495--3/15/2007--ANADYS_PHARMACEUTICALS_INC |
| 1128495--3/15/2006--ANADYS_PHARMACEUTICALS_INC |
| 1172480--3/6/2009--SANTARUS_INC |
| 1172480--3/6/2007--SANTARUS_INC |
| 1116463--3/12/2008--ORASURE_TECHNOLOGIES_INC |
| 1172480--3/4/2010--SANTARUS_INC |
| 805326--3/25/2010--EMISPHERE_TECHNOLOGIES_INC |
| 805326--3/16/2009--EMISPHERE_TECHNOLOGIES_INC |
| 912061--3/31/2008--NATURAL_HEALTH_TRENDS_CORP |
| 1084557--3/31/2008--TASKER_PRODUCTS_CORP |
| 1180145--3/14/2008--REPLIDYNE_INC |
| 912061--3/28/2007--NATURAL_HEALTH_TRENDS_CORP |
| 1180145--3/27/2007--REPLIDYNE_INC |
| 912061--5/8/2006--NATURAL_HEALTH_TRENDS_CORP |
| 1172480--3/7/2006--SANTARUS_INC |
| 805326--3/17/2008--EMISPHERE_TECHNOLOGIES_INC |
|
| related topics |
| {product, candidate, development} |
| {product, liability, claim} |
| {property, intellectual, protect} |
| {interest, director, officer} |
| {financial, litigation, operation} |
| {customer, product, revenue} |
| {cost, contract, operation} |
| {provision, law, control} |
| {system, service, information} |
| {condition, economic, financial} |
| {operation, international, foreign} |
| {acquisition, growth, future} |
| {stock, price, operating} |
| {operation, natural, condition} |
| {gas, price, oil} |
| {control, financial, internal} |
| {debt, indebtedness, cash} |
| {loss, insurance, financial} |
| {personnel, key, retain} |
| {regulation, change, law} |
|